• Publications
  • Influence
Classification of the cutaneous manifestations of COVID‐19: a rapid prospective nationwide consensus study in Spain with 375 cases
The cutaneous manifestations of COVID‐19 disease are poorly characterized and there are no known treatments for this disease.
Risk of serious adverse events associated with biologic and nonbiologic psoriasis systemic therapy: patients ineligible vs eligible for randomized controlled trials.
The use of systemic therapy for psoriasis in patients not adequately represented in randomized controlled trials (RCTs) and the risk of serious adverse events (SAEs) in these patients are described and patients ineligible for RCTs are an important proportion of those receiving systemic therapy.
Toxic epidermal necrolysis and Stevens-Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death?
BACKGROUND Withdrawal of the drug(s) that cause severe cutaneous adverse reactions is usually recommended without proof that it alters the course of those reactions. OBJECTIVE To determine whether
Risk of adverse events in psoriasis patients receiving classic systemic drugs and biologics in a 5‐year observational study of clinical practice: 2008–2013 results of the Biobadaderm registry
Biobadaderm is the Spanish registry of psoriasis patients receiving systemic treatment in clinical practice and aims to improve the quality of care for patients with Psoriasis.
Incidence and risk of hospitalisation due to shingles and chickenpox in patients with rheumatic diseases treated with TNF antagonists
Patients suffering rheumatic diseases exposed to TNF antagonists are hospitalised due to VZV infections significantly more frequently than expected in the general population.
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
A network meta-analysis of randomised controlled trials of systemic and biological treatments in adults with moderate to severe plaque psoriasis or psoriatic arthritis and a ranking of these treatments according to their efficacy and safety is conducted.
Infantile pyramidal protrusion as a manifestation of lichen sclerosus et atrophicus.
Infantile perianal pyramidal protrusion is a peculiar form of lichen sclerosus et atrophicus that can precede other, more characteristic manifestations that can help to explain anogenital symptoms and avoid its misinterpretation as a sign of sexual abuse.
Use of off-label doses is frequent in biologic therapy for moderate to severe psoriasis: A cross-sectional study in clinical practice
Off-label doses of biologic agents for psoriasis are frequent in clinical practice, especially relevant for pharmacoeconomic models.